Bladder Cancer
Kidney Cancer
EAU Edu Platform on Prostate Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Upcoming event
Masterclass on Focal therapy for localised prostate cancer
Home
/
Events
Back
Tags
Abiraterone
,
Active surveillance
,
Adjuvant
,
ADT
,
Advanced prostate cancer
,
Alkaline phosphatase
,
Alternative splicing
,
Androgen
,
Androgen deprivation therapy
,
Androgen pathway blockade
,
Androgen receptor inhibitor
,
Antiandrogens
,
Anticancer agents
,
ARCHES
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
BHC80
,
Biochemical recurrence
,
Biomarkers
,
Biopsy
,
Bisphosphonates
,
Bone metastases
,
BRCA1
,
BRCA2
,
Castrate-resistanter
,
Castration-resistant
,
Chemotherapy
,
Clinical trial
,
Clinical trials
,
Cohort study
,
COVID-19
,
cSP
,
Deferred treatment
,
Diagnosis
,
Disease progression
,
Docetaxel
,
EAU21
,
EAU22
,
Emission-computed
,
EMUC21
,
EMUC22
,
End-to-side nerve grafting
,
Enzalutamide
,
Erectile dysfunction
,
Erectile function
,
ESMO21
,
ESMO22
,
ESOU Online
,
ESU Masterclass
,
ESU Masterclasses
,
External beam radiotherapy
,
Focal therapy
,
Frozen section
,
Fusion biopsies
,
Genomic classifier
,
Genomics
,
Guidelines
,
hormone-sensitive
,
HORRAD
,
HRQL
,
Image guided biopsy
,
Imaging
,
Immunohistochemistry
,
Index lesion
,
Indocyanine green
,
Intensity-modulated radiotherapy
,
Local radiotherapy
,
Localised
,
Localized
,
Localized prostate cancer
,
Lymph node excision
,
Lymphadenectomy
,
Mapping
,
Mass spectrometry
,
Masterclass
,
Masterclasses
,
MDV3100
,
Membranous urethra
,
Meta-analysis
,
Metastasis
,
Metastasized
,
Metastatic
,
Mortality reduction
,
mp-MRI
,
MRI
,
Neoplasm staging
,
Nerve sparing
,
Next-generation sequencing
,
Nomogram
,
Noncastrate
,
Orchiectomy
,
Overdiagnosis
,
p53
,
Patient information
,
PCa21
,
Penile rehabilitation
,
PET/CT
,
Positron emission tomography
,
Precision medicine
,
Pretreatment risk stratification
,
Pretreatment tables
,
Primary tumor treatment
,
Prognosis
,
Prognostic model
,
Prostasomes
,
Prostate screening
,
Prostate-specific antigen
,
Prostate-specific membrane antigen
,
Prostatic neoplasms
,
ProtecT trial
,
Proteomics
,
PSA
,
PSA flare
,
PSA kinetics
,
PSA screening
,
PSMA PET/CT
,
PTEN
,
Quality of life
,
Radiation therapy
,
Radical prostatectomy
,
Randomized prospective trial
,
Randomized trial
,
Randomized trials
,
Rapid metastasis
,
Rb
,
RB1
,
Receptors
,
Risk stratification
,
RNA splicing
,
Robotic prostatectomy
,
Robotic surgery
,
Robotic Urology
,
Robotics
,
Salvage therapy
,
Screening
,
Sentinel lymph node
,
Sexual quality of life
,
SREs
,
SRRM4
,
STAMPEDE
,
Stereotactic body radiotherapy
,
Surgical margins
,
Surgical video
,
Surgical videos
,
Systematic biopsy
,
Systematic review
,
Targeted Biopsy
,
TITAN
,
TP53
,
Transcriptome
,
Transperineal template biopsy
,
Tumor suppressor genes
,
Ultrasensitive PSA
,
Urinary incontinence
,
Urological surgery
,
Urowebinar
,
WCRF/AICR CUP
,
Webinar
,
Wnt
,
Zoledronic acid
Show all
5 - 6 December 2024
Masterclass on Focal therapy for localised prostate cancer
Location: Paris, France
View
21 - 24 March 2025
40th Annual EAU Congress
Location: Madrid, Spain
View
22 - 23 May 2025
Masterclass on Prostate biopsy
Location: Marseille, France
View